Inventor · disambiguated record
Thomas Beauregard Schofield
Also filed as: SCHOFIELD THOMAS BEAUREGARD
8 granted patents·4 pending applications·5 citations·filing 2017–2025
76Inventor score
Top patents by PatentIndex Score
12 records- 0185US12037336B2Compounds with activity as inhibitors of the epithelial sodium channel (ENaC)ENTERPRISE THERAPEUTICS LTD·Filed 2019·Granted Jul 16, 2024·3 cites·30 claims
- 0280US11364246B2CompoundsTMEM16A LTD·Filed 2019·Granted Jun 21, 2022·2 cites·11 claims
- 0377US12371436B2Substituted benzodiazoliums as ENaC inhibitorsENTERPRISE THERAPEUTICS LTD·Filed 2023·Granted Jul 29, 2025·0 cites·24 claims
- 0476US2025304590A1Benzodiazolium compounds as enac inhibitorsENTERPRISE THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 0566US11739094B2Substituted benzodiazoliums as ENaC inhibitorsENTERPRISE THERAPEUTICS LTD·Filed 2020·Granted Aug 29, 2023·0 cites·26 claims
- 0662US10941149B2Substituted benzodiazoliums as ENaC inhibitorsENTERPRISE THERAPEUTICS LTD·Filed 2017·Granted Mar 9, 2021·0 cites·21 claims
- 0761US12377105B2CompoundsTMEM16A LTD·Filed 2022·Granted Aug 5, 2025·0 cites·14 claims
- 0859US2024132467A1Benzimidazole derivatives for treating respiratory diseaseTMEM16A LTD·Filed 2023·Application pending·0 cites
- 0949US2022235006A1Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditionsTMEM16A LTD·Filed 2022·Application pending·0 cites
- 1043US2020361871A1CompoundsENTPR THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1141US11370778B2Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseasesENTERPRISE THERAPEUTICS LTD·Filed 2018·Granted Jun 28, 2022·0 cites·10 claims
- 1235US10759785B2CompoundsENTERPRISE THERAPEUTICS LTD·Filed 2017·Granted Sep 1, 2020·0 cites·32 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Beauregard Schofield files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →